Opus Genetics Inc. has announced new equity awards for two recently hired employees, including James Farrell, the newly appointed Executive Director of Business Development. Farrell received an option to purchase 175,000 shares of company common stock, while another non-executive employee received an option for 189,448 shares. The options have an exercise price set at the fair market value on the grant date and will vest over four years, with 25% vesting after one year and the remaining 75% vesting in quarterly installments thereafter.